Publicaciones en las que colabora con Luisa Maria Seoane Camino (80)

2024

  1. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

  2. Novel mechanisms involved in leptin sensitization in obesity

    Biochemical Pharmacology, Vol. 223

2023

  1. Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e145-e154

  2. Editorial: Central and peripheral mechanism interfering in metabolic syndrome

    Frontiers in Endocrinology

2022

  1. Crosstalk between Melanin Concentrating Hormone and Endocrine Factors: Implications for Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  2. Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  3. Liver Brain Interactions: Focus on FGF21 a Systematic Review

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  4. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. Conversion from Duodenal Switch to Single Anastomosis Duodenal Switch to Deal with Postoperative Malnutrition

    Obesity Surgery, Vol. 31, Núm. 1, pp. 431-436

  2. Hypothalamic actions of SIRT1 and SIRT6 on energy balance

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-11

  3. Relevance of nutritional assessment and treatment to counteract cardiac cachexia and sarcopenia in chronic heart failure

    Clinical Nutrition, Vol. 40, Núm. 9, pp. 5141-5155

2020

  1. MTOR pathway is involved in energy homeostasis regulation as a part of the gut–brain axis

    International Journal of Molecular Sciences, Vol. 21, Núm. 16, pp. 1-12

  2. Oral Pharmacological Activation of Hypothalamic Guanylate Cyclase 2C Receptor Stimulates Brown Fat Thermogenesis to Reduce Body Weight

    Neuroendocrinology, Vol. 110, Núm. 11-12, pp. 1042-1053

2019

  1. ANGPTL-4 is associated with obesity and lipid profile in children and adolescents

    Nutrients, Vol. 11, Núm. 6

  2. Uroguanylin improves leptin responsiveness in diet-induced obese mice

    Nutrients, Vol. 11, Núm. 4

2018

  1. Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty

    Scientific Reports, Vol. 8, Núm. 1

  2. Plasma ANGPTL-4 is Associated with Obesity and Glucose Tolerance: Cross-Sectional and Longitudinal Findings

    Molecular Nutrition and Food Research, Vol. 62, Núm. 10

  3. Uroguanylin: A new actor in the energy balance movie

    Journal of Molecular Endocrinology, Vol. 60, Núm. 2, pp. R31-R38

2017

  1. Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway

    World Journal of Gastroenterology, Vol. 23, Núm. 35, pp. 6403-6411

  2. Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity

    Endocrine, Vol. 55, Núm. 2, pp. 435-446